Andere Sprachen Bayer AG

Aktien

BAY001

DE000BAY0017

BAYN

Pharmazeutika

Realtime-Estimate Tradegate Andere Börsenplätze 17:26:14 29.04.2025			% 5 Tage	% 1. Jan.
23,18 ^EUR	+0,88 %		+7,94 %	+20,07 %

12:48	Mwb Research erwartet Erholung von Bayer bis 2026, 2027	MT
10:06	Finanzvorstand von Clariant tritt in den Ruhestand; Nachfolger benannt	MT

Andere Sprachen

Mwb research Expects Bayer Rebound By 2026, 2027	12:48
Bayer : Climate Advocacy Report 2024 (bayer climate advocacy report 2024 final)	11:05
Clariant CFO to Retire; Successor Named	10:06
Guru Ramamurthy Appointed As New CFO For Bayer's Crop Science Division	07:12
Bayer Announces Changes to CFO for Crop Science Division, Effective July 1, 2025	07:00
Bayer : Notice of Dividend 2025	28.04.
BridgeBio Pharma's Beyonttra Approved in UK for Heart Condition due to Amyloidosis	28.04.
BridgeBio Pharma, Inc. Announces Beyonttra®? Approved by the UK Medicines and Healthcare Products Regulatory Agency to Treat ATTR-CM	28.04.
Bayer doute de l'avenir de son herbicide au glyphosate	25.04.
Bayer CEO: Currently No Plans To Separate Businesses, But Not Excluded Longer Term	25.04.
Bayer n'exclut pas de renoncer au glyphosate	25.04.
Bayer Plans New Launches to Offset Xarelto Patent Expiry	25.04.
Bayer : Explanations relating to the Supervisory Board Report	25.04.
Bayer : Address by Bill Anderson	25.04.
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	24.04.
AlphaValue/Baader Europe Slashes Bayer Price Target as Legal Issues Persist	23.04.
Farmacéuticas europeas presionan para subir precios en la UE ante amenazas de aranceles de EEUU	23.04.
European pharma companies push for higher drug prices in EU amid U.S. tariff threats	23.04.
BAYER : No solution in sight	23.04.
Concertai Announce Strategic Agreement With Bayer	22.04.
Bayer CEO Says to Pull Back Glyphosate from Market Amid Rising Litigation Costs	18.04.
Bayer lobbies US states in battle to keep glyphosate on market, CEO says	17.04.
Bayer CEO In Speech For AGM Says Have Committed To Significantly Containing Litigation By End Of 2026	17.04.
Bayer CEO: targeting US state regulation to stem glyphosate costs	17.04.
Bayer Unveils $44 Million Investment in Myerstown, Pa Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community	16.04.

Keine Ergebnisse zu dieser Suche

Mehr Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

BAYER : Keine Lösung in Sicht

Am 23. April 2025 um 11:14 Uhr

Bayer AG: Ein Drahtseilakt

Am 13. November 2024 um 17:48 Uhr